Cargando…
Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation
BACKGROUND: Cigarette smoke exposure is the major risk factor for developing COPD. Presently, available COPD treatments focus on suppressing inflammation and providing bronchodilation. However, these options have varying efficacy in controlling symptoms and do not reverse or limit the progression of...
Autores principales: | Bazett, Mark, Biala, Agnieszka, Huff, Ryan D., Zeglinksi, Matthew R., Hansbro, Philip M., Bosiljcic, Momir, Gunn, Hal, Kalyan, Shirin, Hirota, Jeremy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433159/ https://www.ncbi.nlm.nih.gov/pubmed/28506308 http://dx.doi.org/10.1186/s12931-017-0577-y |
Ejemplares similares
-
A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease
por: Bazett, Mark, et al.
Publicado: (2016) -
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology
por: Kalyan, Shirin, et al.
Publicado: (2020) -
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis
por: Sham, Ho Pan, et al.
Publicado: (2018) -
Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
por: Sutcliffe, Simon, et al.
Publicado: (2019) -
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy
por: Bazett, Mark, et al.
Publicado: (2017)